Form 4: DaVita Chief Accounting Officer Awarded RSUs

DaVita's Chief Accounting Officer, Christopher Michael Berry, was granted 3,649 restricted stock units, increasing his beneficial ownership to 19,640 shares.

Summary

• Christopher Michael Berry, Chief Accounting Officer of DaVita Inc. (DVA), acquired 3,649 shares of common stock.
• The transaction date for this acquisition was March 15, 2026.
• These acquired shares are restricted stock units (RSUs) with a specific vesting schedule.
• 50% of the granted RSUs are scheduled to vest on March 15, 2029, and the remaining 50% on March 15, 2030.
• Following this reported transaction, Mr. Berry beneficially owns a total of 19,640 shares of DaVita common stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as the grant of restricted stock units to a key executive aligns their long-term interests with shareholder value, a standard practice in corporate governance.

Positives

• The grant of 3,649 restricted stock units to a key executive, Christopher Michael Berry, aligns management's long-term interests with shareholder value.
• Increased beneficial ownership of common stock by the Chief Accounting Officer to 19,640 shares demonstrates continued commitment to the company.

Future Outlook

The restricted stock units granted to the Chief Accounting Officer are scheduled to vest in two equal tranches on March 15, 2029, and March 15, 2030, subject to the terms of the applicable award agreement.

Industry Context

StockSavvy.ai notes that executive equity grants, such as restricted stock units, are a common practice across industries to incentivize long-term performance and align executive interests with those of shareholders. This particular grant to DaVita's Chief Accounting Officer is consistent with typical compensation structures in the healthcare services sector.

Comparison to Industry Standards

• The grant of restricted stock units to a Chief Accounting Officer is a standard practice for executive compensation in publicly traded companies, including those in the healthcare sector like DaVita.
• Companies such as Fresenius Medical Care AG & Co. KGaA (FMS) and Baxter International Inc. (BAX) also frequently utilize equity-based compensation to retain and motivate key executives, with vesting schedules often spanning several years to encourage sustained performance.

Related Party Transactions

• Grant of 3,649 restricted stock units to Christopher Michael Berry, the Chief Accounting Officer, as part of his executive compensation package.

Stakeholder Impact

• Shareholders: Increased alignment of executive interests with long-term company performance and shareholder value creation.
• Employees: Standard executive compensation practices can positively influence morale and retention of key personnel within the organization.

Next Steps

• First tranche of 50% of the restricted stock units to vest on March 15, 2029.
• Second tranche of 50% of the restricted stock units to vest on March 15, 2030.

Key Dates

Recommendation

This Form 4 filing reports a routine grant of restricted stock units to a key executive, which is a standard component of executive compensation. While it aligns management's interests with shareholders, it does not present new information that would fundamentally alter the investment thesis for DaVita Inc., thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

DaVita, DVA, Form 4, insider transaction, restricted stock units, RSU, executive compensation, beneficial ownership, Christopher Michael Berry